GDUFA III Calculation Faces Rising Staff Costs

Generic Drug User Fee Projections Complicated By Shifting Personnel Costs

inflation and deflation graph
The FDA and industry are discussing potential changes to GDUFA user fee calculations as part of renewal negotiations • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Generics

More from Products